Cites del registre

Cita APA (7th ed.)
Ingersoll, M. A., Lutze, R. D., Pushpan, C. K., Kelmann, R. G., Liu, H., May, M. T., . . . Teitz, T. (2023). Dabrafenib protects from cisplatin-induced hearing loss in a clinically relevant mouse model. American Society for Clinical investigation.
Cita Chicago (17th ed.)
Ingersoll, Matthew A., Richard D. Lutze, Chithra K. Pushpan, Regina G. Kelmann, Huizhan Liu, Mark T. May, William J. Hunter, David Z.Z He, i Tal Teitz. Dabrafenib Protects from Cisplatin-induced Hearing Loss in a Clinically Relevant Mouse Model. American Society for Clinical investigation, 2023.
Cita MLA (9th ed.)
Ingersoll, Matthew A., et al. Dabrafenib Protects from Cisplatin-induced Hearing Loss in a Clinically Relevant Mouse Model. American Society for Clinical investigation, 2023.
Atenció: Aquestes cites poden no estar 100% correctes.